Walory J, Grzesiowski P, Hryniewicz W
Department of Immunology and Prevention of Infection, Sera and Vaccines Central Research Laboratory, Warsaw, Poland.
J Immunol Methods. 2000 Nov 1;245(1-2):55-65. doi: 10.1016/s0022-1759(00)00273-8.
The aim of this study was to compare four serological methods for the detection of Corynebacterium diphtheriae IgG anti-toxin antibodies (IgG-DTAb) in human serum. One hundred serum samples were evaluated for C. diphtheriae IgG-DTAb by four different methods: passive haemagglutination (PHA), latex agglutination test (LA), toxoid enzyme-linked immunosorbent assay (Toxoid-ELISA), and toxin-binding inhibition enzyme-linked immunosorbent assay (ToBI-ELISA). As the external standardisation the neutralisation test for C. diphtheriae toxin in Vero cells (TN Vero) was used. For internal standardisation of IgG-DTAb titres, the WHO standard serum of human diphtheria antitoxin was used. The study revealed a poor correlation between the reference test and the PHA (r=0.34 Pearson's correlation coefficient), an acceptable correlation for the LA (r=0.74), a good correlation for the Toxoid-ELISA (r=0.81) and a very good correlation for ToBI-ELISA (r=0.93). The sensitivity measurements of PHA, LA, Toxoid-ELISA and ToBI-ELISA tests, were 14, 100, 94, 96% respectively and the corresponding specificity characteristics were 86, 76, 94, 90 respectively. Of the four evaluated methods, the ToBI-ELISA could be recommended for scientific and precise laboratory assays of diphtheria antibody levels in humans. For screening purposes the Toxoid-ELISA could be used, but the accuracy of antibody titres below 0.1 IU/ml, considered as the limits of protection, is questionable. Both tests offer very useful alternatives to the in vitro diphtheria toxin neutralisation test in Vero cells. Because of their unsatisfactory correlation and sensitivity as compared to the reference method, PHA and LA should be avoided and replaced by one of the two enzyme immunoassays.
本研究的目的是比较四种血清学方法检测人血清中白喉棒状杆菌IgG抗毒素抗体(IgG-DTAb)。采用四种不同方法对100份血清样本进行白喉棒状杆菌IgG-DTAb检测:被动血凝试验(PHA)、乳胶凝集试验(LA)、类毒素酶联免疫吸附测定(类毒素-ELISA)和毒素结合抑制酶联免疫吸附测定(ToBI-ELISA)。作为外部标准化,采用Vero细胞中白喉棒状杆菌毒素中和试验(TN Vero)。对于IgG-DTAb滴度的内部标准化,使用世界卫生组织人白喉抗毒素标准血清。研究显示,参考试验与PHA之间的相关性较差(Pearson相关系数r=0.34),LA的相关性尚可(r=0.74),类毒素-ELISA的相关性良好(r=0.81),ToBI-ELISA的相关性非常好(r=0.93)。PHA、LA、类毒素-ELISA和ToBI-ELISA试验的灵敏度测量值分别为14%、100%、94%、96%,相应的特异性特征分别为86%、76%、94%、90%。在四种评估方法中,ToBI-ELISA可推荐用于科学、精确地检测人体白喉抗体水平的实验室检测。对于筛查目的,可使用类毒素-ELISA,但抗体滴度低于0.1 IU/ml(视为保护极限)的准确性值得怀疑。这两种试验都为Vero细胞体外白喉毒素中和试验提供了非常有用的替代方法。由于与参考方法相比,PHA和LA的相关性和灵敏度不理想,应避免使用,并由两种酶免疫测定方法之一替代。